[ Aphea.Bio raises $10.1M in Series A ]

Aphea.Bio has raised $10.1 million in Series A funding.

Founded in 2017, Aphea.Bio  is engaged in the development of biopesticides to protect agricultural products from fungal diseases.

Aphea.Bio will also develop novel ‘biostimulants,’ with the aim of stimulating crop growth through various processes, such as promoting the uptake of nutrients from the soil.

Funding  Series A
Founded  2017
Country  Belgium
City  Zwijnaarde, Oost-Vlaanderen
Founder / CEO  Isabel Vercauteren
Deal Size  $10.1M
Investors  Gemma Frisius Fund KU Leuven
 V-Bio Ventures
 Group De Ceuster
 Vives Fund
 VIB
 Qbic Fund
 PMV
 Agri Investment Fund
Previous Investors  /